Portal de Periódicos da CAPES

Amiodarone and the thyroid: pharmacological, toxic and therapeutic effects

1993; Wiley; Volume: 233; Issue: 6 Linguagem: Inglês

10.1111/j.1365-2796.1993.tb00997.x

1365-2796

J. Unger, M. Lambert, Marc Jonckheer, Ph. DENAYER,

Ion channel regulation and function

Journal of Internal MedicineVolume 233, Issue 6 p. 435-443 Free Access Amiodarone and the thyroid: pharmacological, toxic and therapeutic effects J. UNGER, Corresponding Author J. UNGER Department of Endocrinology, Erasme Hospital and IRIBHN (ULB), Brussels, BelgiumDepartment of Endocrinology, Erasme Hospital, 808, route de Lennik, B-1070 Brussels, BelgiumSearch for more papers by this authorM. LAMBERT, M. LAMBERT Departments of Internal Medicine, Brussels, BelgiumSearch for more papers by this authorM. H. JONCKHEER, M. H. JONCKHEER Department of Nuclear Medicine, Academic Hospital (VUB), Brussels, BelgiumSearch for more papers by this authorPh. DENAYER, Ph. DENAYER Nuclear Medicine, Saint-Luc Hospital, (UCL), Brussels, BelgiumSearch for more papers by this author J. UNGER, Corresponding Author J. UNGER Department of Endocrinology, Erasme Hospital and IRIBHN (ULB), Brussels, BelgiumDepartment of Endocrinology, Erasme Hospital, 808, route de Lennik, B-1070 Brussels, BelgiumSearch for more papers by this authorM. LAMBERT, M. LAMBERT Departments of Internal Medicine, Brussels, BelgiumSearch for more papers by this authorM. H. JONCKHEER, M. H. JONCKHEER Department of Nuclear Medicine, Academic Hospital (VUB), Brussels, BelgiumSearch for more papers by this authorPh. DENAYER, Ph. DENAYER Nuclear Medicine, Saint-Luc Hospital, (UCL), Brussels, BelgiumSearch for more papers by this author First published: June 1993 https://doi.org/10.1111/j.1365-2796.1993.tb00997.xCitations: 16AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Vastesaeger M, Gillet, P, Rasson G. Etude clinique d'une nouvelle médication antiangoreuse. Acta Cardiol 1967; 22: 483– 500. 2 Charlier R, Delaunois G, Bauthier J, Deltour G. Antiarrhythmic properties of amiodarone. Cardiologie 1969; 54: 83– 90. 3 Massin JP, Thomopoulos P, Karam J, Savoie JC. Le risque thyroïdien d'un nouveau coronaro-dilatateur iodé: l'amiodarone (Cordarone). Ann Endocrinol (Paris) 1971; 32: 438– 48. 4 Jonckheer MH, Blockx P, Kaivers R, Wyffels G. Hyperthyroidism as a possible complication of the treatment of ischemic heart disease with amiodarone. Acta Cardiol 1973; 28: 192– 200. 5 Burger A, Dinichert D, Nicod P, Jenny M, Lemarchand-Beraud T, Valloton M. Effects of amiodarone on serum T3, rT3, T4 and TSH. A drug influencing peripherals metabolism of thyroid hormones. J Clin Invest 1976; 58: 255– 9. 6 Jonckheer MH, Blockx P, Broeckaert I, Cornette C, Beckers C. Low T3 syndrome in patients chronically treated with an iodine-containing drug, amiodarone. Clin Endocrinol 1978; 9: 27– 35. 7 Lambert MJ, Burger AG, Galeazzi RL, Engler D. Are selective increase in serum thyroxine (T4) due to iodinated inhibitors of T4 monodeiodination indicative of hyperthyroidism? J Clin Endocrinol Metab 1982; 55: 1058– 65. 8 Van Reeth O, Decoster C, Unger J. Effect of amiodarone on serum T4 and T3 levels in hyperthyroid patients treated with methimazole. Eur J Clin Pharmacol 1987; 32: 223– 7. 9 Broekhuysen J, Laruel R, Sion R. Recherches dans la série des benzofurannes XXXVII. Etude comparée du transit et du métabolisme de l'amiodarone chez diverses espèces animales et chez l'homme. Arch Int Pharmacodyn 1969; 177: 340– 59. 10 Holt DW, Tucker GT, Jackson PR, Storey GCA. Amiodarone pharmacokinetics. Am Heart J 1983; 106: 840– 47. 11 Plomp TA, van Rossum JM, Robles de Medina EO, van Lier T, Maes RAA. Pharmacokinetics and body distribution of amiodarone in man. Arzneim-Forsch Drug Res 1984; 34: 513– 20. 12 Mason JW. Amiodarone. N Engl J Med 1987; 316: 455– 66. 13 Rao RH, McCready VR, Spathis GS. Iodine kinetic studies during amiodarone treatment. J Clin Endocrinol Metab 1986; 62: 563– 8. 14 Wiersinga WM, Touber JL, Trip MD, Van Royen EA. Uninhibited thyroidal uptake of radioiodine despite iodine excess in amiodarone-induced hypothyroidism. J Clin Endocrinol Metab 1986; 63: 485– 91. 15 Wolff J. Iodide goiter and the pharmacologic effect of excess iodide. Am J Med 1969; 47: 101– 24. 16 Jonckheer MH, Velkeniers B, Vanhaelst L, Van Blerk M. Further characterization of iodide-induced hyperthyroidism based on the direct measurement of intrathyroidal stores. Nucl Med Comm 1992; 13: 114– 18. 17 Jonckheer MJ, Deconinck F. X-ray fluorescence determination of stable iodine in the thyroid gland. A review. Acta Clin Belg 1982; 37: 30– 10. 18 Léger AF, Fragu P, Rougier P, Laurent MF, Tubiana M, Savoie JC. Thyroid iodine content measured by X-ray fluorescence in amiodarone-induced thyrotoxicosis: concise communication. J Nucl Med 1983; 24: 582– 585. 19 Gheri RG, Biagini C, Colagrande S, Cesarino G, Serio M. Application of computed tomographic scanning to predict the occurence of hypothyroidism in amiodarone treated patients. In: HA Drexhage, JJM Vijlder, WM Wiersinga, eds. The Thyroid Gland. Environment and Autoimmunity. Amsterdam: Elsevier Science Publishers, 1990; 207– 10. 20 Jonckheer MH. Amiodarone and the thyroid gland. A review. Acta Cardiol 1981; 36: 199– 205. 21 Jonckheer MH. Clinical usefulness of thyroid imaging by means of X-ray fluorescence. Horm Res 1987; 26: 42– 7. 22 Hershman JM, Nademanee K, Sugawara M et al. Thyroxine and triiodothyronine kinetics in cardiac patients taking amiodarone. Acta Endocrinol 1986; 111: 193– 9. 23 Kannan R, Ookhtens M, Chopra IJ, Singh BN. Effects of chronic administration of amiodarone on kinetics of metabolism of iodothyronines. Endocrinology 1984; 115: 1710– 16. 24 Pearce CJ, Himsworth RL. The effect of amiodarone on thyroxine kinetics. Clin Endocrinol 1986; 24: 107– 12. 25 Kaptein EM, Egodage PM, Hoopes MT, Burger AG. Amiodarone alters thyroxine transfer and distribution in humans. Metabolism 1988; 37: 1107– 13. 26 Kannan R, Chopra IJ, Ookhtens M, Singh BN. Effect of amiodarone on non-deiodinative pathway of thyroid hormone metabolism. Acta Endocrinol 1990; 122: 249– 54. 27 Sogol PB, Hershman JM, Reed AW, Dillmann WH. The effects of amiodarone on serum thyroid hormones and hepatic thyroxine 5′-monodeiodination in rats. Endocrinology 1983; 113: 1464– 9. 28 Aanderud S, Sundsfjord J, Aarbakke J. Amiodarone inhibits the conversion of thyroxine to triiodothyronine in isolated rat hepatocytes. Endocrinology 1984; 115: 1605– 8. 29 Pekary AE, Hershman JM, Reed AW, Kannon R, Wang YS. Amiodarone inhibits T4 to T3 conversion and α-glycerophosphate dehydrogenase and malic enzyme levels in rat liver. Horm Metabol Res 1986; 18: 114– 18. 30 Gotzsche LBH, Boye N, Laurberg P, Andreasen F. Rat heart thyroxine 5′-deiodinase is sensitively depressed by amiodarone. J Cardiovasc Pharmacol 1989; 14: 836– 41. 31 Meese RS, Smitherman TC, Croft CJ, Burger A, Nicod P. Effect of peripheral hormone metabolism on cardiac arrhythmias. Am J Cardiol 1985; 55: 849– 50. 32 Melmed S, Nademanee K, Reed AW, Hendrickson JA, Singh BN, Hershman JM. Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration. J Clin Endocrinol Metab 1981; 53: 997– 1001. 33 Sheldon J. Effects of amiodarone in thyrotoxicosis. Br Med J 1983; 286: 267– 8. 34 Shian LR, Yen CY, Bian TY, Huang HW, Shen DC, Wu SY. A comparative study of the early therapeutic effect of amiodarone and iodine on Graves' thyrotoxicosis (Abstract). Clin Res 1985; 33: 29A. 35 Rajatanavin R, Chailurkit L, Kongsuksai A, Teeravaninthorn U, Himathongkam T. The effect of amiodarone on the control of hyperthyroidism by propylthiouracil. Clin Endocrinol 1990; 33: 193– 203. 36 Nagataki S. Effect of excess quantities iodide. In: MA Green, DH Solomon, eds. Handbook of Physiology, vol. 3. Baltimore: Waverly Press, 1974; 329– 44. 37 Figge HL, Figge J. The effects of amiodarone on thyroid hormone function: a review of the physiology and clinical manifestations. J Clin Pharmacol 1990; 30: 588– 95. 38 Safran M, Fang SL, Bambini G, Pinchera A, Martino E, Braverman LE. Effects of amiodarone and desethylamiodarone on pituitary deiodinase activity and thyrotropin secretion in the rat. Am J Med Sc 1986; 292: 136– 41. 39 Franklyn JA, Gamage MD, Sheppard MC. Amiodarone and thyroid hormone effects on anterior pituitary hormone gene expression. Clin Endocrinol 1987; 27: 373– 82. 40 Norman MF, Lavin TN. Antagonism of thyroid hormone action by amiodarone in rat pituitary tumor cells. J Clin Invest 1989; 83: 306– 13. 41 Roussel JP, De Nayer Ph, Astier H. l'amiodarone et la desethylamiodarone antagonisent l'effet inhibiteur de la T3 sur la réponse au TRH. Etude in vitro Ann Endocrinol 1991; 52: 216. 42 Figge J, Dhuly RG. Amiodarone-induced elevation of thyroid stimulating hormone in patients receiving levothyroxine for primary hypothyroidism. Ann Intern Med 1990; 113: 553– 5. 43 Silva EJ, Leonard JL. Regulation of rat cerebrocortical and adenohypophyseal type II 5-deiodinase by thyroxin, triiodothyronine and reverse triiodothyronine. Endocrinology 1985; 116: 1627– 35. 44 Lambert M, Burger A. Amiodarone and TRH-stimulation test. Acta Clin Belg 1982; 37: 250– 51. 45 Lambert M, Burger AG, De Nayer Ph, Beckers C. Decreased TSH response to TRH induced by amiodarone. Acta Endocrinol 1988; 118: 449– 52. 46 Latham KR, Selliti DF, Goldstein RE. Interaction of amiodarone and desethylamiodarone with solubilized nuclear thyroid hormone receptors. J Am Coll Cardiol 1987; 2: 872– 6. 47 Bagchi N, Brown TR, Schneider DS, Banerjee SK. Effect of amiodarone on rat heart myosin isoenzymes. Circ Res 1987; 60: 621– 5. 48 Kennedy RL, Griffiths H, Gary TA. Amiodarone and the thyroid. Clin Chem 1989; 35: 1882– 7. 49 Paradis P, Lambert C, Rouleau J. Amiodarone antagonizes the effects of T3 at the receptor level: an additional mechanism for its in vivo hypothyroid-like effects. Can J Physiol Pharmacol 1991; 69: 865– 70. 50 Hartong R, Wiersinga WM, Lamers WH, Plomp TA, Broenink M, Van Beeren MH. Effects of amiodarone on thyroid hormoneresponsive gene expression in rat liver. Horm Metabol Res 1987; 17: 34– 43. 51 Wilson DB. Does amiodarone inhibit T3 binding to solubilized nuclear receptors in vitro? Horm Metabol Res 1989; 21: 483– 8. 52 Martino E, Aghini-Lombardi F et al. Amiodarone iodineinduced hypothyroidism: risk factors and follow-up in 28 cases. Clin Endocrinol 1987; 26: 227– 37. 53 Martino E, Aghini-Lombardi F, Mariotti S, Bartalena M, Braveman LE, Pinchera A. Amiodarone: a common source of iodine-induced thyrotoxicosis. Horm Res 1987; 26: 158– 71. 54 Amico JA, Richardson V, Alpert B, Klein I. Clinical and chemical assessment of thyroid function during therapy with amiodarone. Arch Int Med 1984; 144: 487– 90. 55 Jonckheer MH, Broeckaert I, Blockx P, Bernard R. Amiodarone et fonction thyroïdienne. Arch Mal Coeur 1976; 12: 1315– 19. 56 Jonckheer MH, Huyghens L. Effects of amiodarone on the thyroid gland. In: G Breithardt, F Loogan, eds. New Aspects in the Medical Treatment of Tachyarrythmias. München: Urban & Schwarzenberg, 1983; 239– 14. 57 Jonckheer MH. Amiodarone therapy and hyperthyroidism in Europe. Arch Intern Med 1984; 144: 2429. 58 Martino E, Safran M. Aghini-Lombardi F et al. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med 1984; 101: 28– 34. 59 Nademanee K, Piwonka RW, Singh BN, Hershman JM. Amiodarone and thyroid function. Prog Cardiovasc Dis 1989; 31: 427– 37. 60 Gluzman BE, Coleoni AH, Targovnik HM, Niepomniszcze H. Effects of amiodarone on thyroid iodine metabolism in vitro. Acta Endocrinol (Kbh) 1977; 85: 781– 90. 61 Pasquali D, Tseng FY, Sheela Rani CS, Field JB. Inhibition of intermediary metabolism by amiodarone in dog thyroid slices. Am J Physiol 1990; 259: E529– 33. 62 Sheela Rani CS. Amiodarone effects on thyrotropin receptors and responses stimulated by thyrotropin and carbachol in cultured dog thyroid cells. Endocrinology 1990; 127: 2930– 37. 63 Smyrk TC, Goellner JR, Brennam MD, Carney JA. Pathology of the thyroid in amiodarone-associated thyrotoxicosis. Am J Surg Pathol 1987; 11: 197– 204. 64 Hall R, Turner-Warwick M, Doniach D. Autoantibodies in iodide goitre and asthma. Clin Exp Immunol 1966; 1: 285– 9. 65 Unger J, Surmont DWA, Sarot J, Soupart A, Dumont JE. 24-h kinetics of iodide uptake in amiodarone induced hypothyroidism. Thyroidology 1989; 2: 101– 2. 66 Coffernils M, Owen A, Unger J. Reversible hypothyroidism detected by normal 99m Tc scan. Postgr Med J 1989; 65: 958– 9. 67 Briançon C, Halpern S, Telenczak P, Fragu P. Changes in 127I mice thyroid follicle studied by analytical ion microscopy: a key for the comprehension of amiodarone-induced thyroid diseases. Endocrinology 1990; 127: 1502– 9. 68 Fragu Ph, Schlumberger M, Davy JM, Slama M, Berdeaux A. Effects of amiodarone therapy on thyroid iodine content as measured by X-ray fluorescence. J Clin Endocrinol Metab 1988; 66: 762– 9. 69 Fradkin JE, Wolff J. Iodide-induced thyrotoxicosis. Medicine 1983; 62: 1– 20. 70 Martino E, Aghini-Lombardi F, Mariotti S et al. Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole. J Endocrinol Invest 1986; 9: 201– 7. 71 De Weweire A, Linger Ph, Delwiche F, Linger J. Failure to control hyperthyroidism with a thionamide after KClO4 withdrawal in a patient with amiodarone associated thyrotoxicosis. J Endocrinol Invest 1987; 10: 529. 72 Weissel M. Suppression of thyroglobulin secretion in amiodarone iodine-induced thyrotoxicosis. J Endocrinol Invest 1988; 11: 53– 5. 73 Newnham HH, Topliss DJ, Le Grand BA, Chosich N, Harper RW, Stockigt JR. Amiodarone-induced hyperthyroidism: assessment of the predictive value of biochemical testing and response to combined therapy using propylthiouracil and potassium perchlorate. Aust NZ J Med 1988; 18: 37– 44. 74 Linger J. Serum thyroglobulin concentration may be a clue to the mechanism of amiodarone-induced thyrotoxicosis. J Endocrinol Invest 1988; 11: 689. 75 Lambert M, Linger J, De Nayer Ph, Brohet C, Gangji D. Amiodarone-induced thyrotoxicosis suggestive of thyroid damage. J Endocrinol Invest 1990; 13: 527– 30. 76 Leung WH, Pun KK, Lau CP, Wong CK, Wang Ch. Amiodarone-induced thyroiditis. Am Heart J 1989; 118: 848– 9. 77 Beddows SA, Page SR, Taylor AH et al. Cytotoxic effects of amiodarone and desethylamiodarone on human thyrocytes. Biochem Pharmacol 1989; 38: 4397– 103. 78 Bimes C. Nouvelles recherches histologiques et physiopathologiques sur les goitres toxiques iodo-involués. Ann Endocrinol (Paris) 1951; 12: 1008– 29. 79 Follis RH. Further observations on thyroiditis and colloid accumulation in hyperplastic thyroid glands of hamsters receiving excess iodine, Lab Invest 1964; 13: 1590– 99. 80 Belshwa BE, Becker DV. Necrosis of follicular cells and discharge of thyroidal iodine induced by administering iodide to iodine-deficient dogs. J Clin Endocrinol Metab 1973; 36: 466– 73. 81 Mahmoud I, Colin I, Many NC, Denef JF. Direct toxic effect of iodide in excess on iodine-deficient thyroid glands: epithelial necrosis and inflammation associated with lipofuscin accumulation. Exp Mol Pathol 1986; 44: 259– 71. 82 Broussolle C, Ducottet X, Martin C et al. Rapid effectiveness of prednisone and thionamides combined therapy in severe amiodarone iodine induced thyrotoxicosis. Comparison of two groups of patients with apparently normal thyroid glands. J Endocrinol Invest 1989; 12: 37– 12. 83 Péché R, Abramowicz M, Unger J. Failure to respond to dexamethasone with fatal consequences, after initial response to a multidrug treatment in a case of amiodarone-associated thyrotoxicosis. Am J Med 1992; 93: 702– 3. 84 Uzzan B, Pussard E, Leon A et al. The effects of plasmapheresis on thyroid hormone and plasma drug concentrations in amiodarone-induced thyrotoxicosis. Br J Clin Pharmac 1991; 31: 371– 2. 85 Brennan MD, van Heerden JA, Carney JA. Amiodaroneassociated thyrotoxicosis (AAT): experience with surgical management. Surgery 1987; 102: 1062– 7. 86 Davies PH, Franklyn JA, Sheppard MC. Treatment of amiodarone induced thyrotoxicosis with carbimazole alone and continuation of amiodarone. Br Med J 1992; 305: 224– 5. 87 Wu SY, Chapra IJ, Salomon DH, Bennett LR. Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin). J Clin Endocrinol Metab 1978; 46: 691– 7. 88 Fuller PJ, Stockigt JR. Feedback regulation of thyrotropin secretion by thyroid hormones. N Engl J Med 1982; 306: 1237. 89 Van Reeth O, Decoster C, Unger J. Treatment of hyperthyroidism with amiodarone (Abstract). Eur J Clin Invest 1984; 14 (11): 26. 90 Van Reeth O, Unger J. Effects of amiodarone on serum T3 and T4 concentrations in hyperthyroid patients treated with propylthiouracil. Thyroid 1991; 1: 301– 306. 91 Cauchie P, Decaux G, Unger J. Treatment of atrial fibrillation associated with hyperthyroidism by amiodarone and methimazole. Int J Cardiol 1988; 19: 123– 4. 92 Unger J, Mavroudakis N, Lipski A, Van Coevorden A. Treatment of supraventricular tachyarrhythmias associated with hyperthyroidism by radioiodine, amiodarone and propylthiouracil. Thyroidology 1991; 3: 85– 8. Citing Literature Volume233, Issue6June 1993Pages 435-443 ReferencesRelatedInformation